Karen Soares, Clover Health’s chief legal officer, sold 6,846 shares at $4.78 each on 2026-09-15. The transaction represented about 0.4% of her prior holding, and she owned 1,607,371 shares afterward, giving investors the reported scale of the sale and her remaining position.

Key Highlights

  • The transaction occurred on 15 September 2026.
  • The filing lists SEC transaction code S.
  • Karen Soares owned 1,607,371 shares after the transaction.

CLOVER HEALTH INVESTMENTS, CORP. /DE (NASDAQ: CLOV) Chief Legal Officer Karen Soares sold 6,846 shares at $4.78 per share. The filing reported Soares’ sale of shares in the company.

Transaction Date and Filing Code

The sale took place on 15 September 2026. Its SEC transaction code was S. Karen Soares was identified as CLOVER HEALTH INVESTMENTS, CORP. /DE’s chief legal officer. The reported transaction involved 6,846 shares, with each share priced at $4.78. The filing identifies the transaction with SEC code S. The filing gives the sale date as 15 September 2026 and the reported price as $4.78 per share.

Post-Transaction Ownership

Soares owned 1,607,371 shares after completing the sale. The filing states that the transaction represented about 0.4% of her prior shareholding. The filing reports the sale, the percentage of prior shareholding it represented, and the post-transaction ownership figure.